Literature DB >> 26169284

Can pancreatic neuroendocrine tumour biopsy accurately determine pathological characteristics?

Vinciane Rebours1, Jacqueline Cordova2, Anne Couvelard3, Monique Fabre4, Laurent Palazzo5, Marie Pierre Vullierme6, Olivia Hentic2, Alain Sauvanet7, Alain Aubert2, Pierre Bedossa8, Philippe Ruszniewski9.   

Abstract

BACKGROUND: Assessment of the pathological characteristics of pancreatic neuroendocrine tumours is crucial for appropriate management. We compared preoperative pathological data with surgical specimens for accuracy.
METHODS: Surgical patients with pancreatic neuroendocrine tumours who underwent preoperative endoscopic ultrasound-guided fine needle aspiration of the primary tumour or biopsy of liver metastasis were retrospectively included. Tumour differentiation and the Ki67 proliferation index on biopsies were compared with pancreatic specimens.
RESULTS: Fifty-seven patients were included. A preoperative biopsy of the primary tumour or of a liver metastasis was obtained in 48 and 9 patients respectively. Tumour differentiation was high in 98%, and poor in 2% on biopsy and high in 100% of surgical specimens. Ki67 index values were 0 (0-19) and 2 (0-15) on biopsy and surgical specimens (p=0.01). Correlation between preoperative and surgical findings was stronger for liver (r=0.62, p=0.001) than for pancreas (r=0.23, p=0.11). Correlation for pancreas varied according to the tumour pattern: solid (r=0.24, p=0.16), mixed (r=0.91, p=0.0036) or cystic (r=0.04, p=0.89). Tumour grade was different between pancreatic biopsies and surgical specimens, for grade 1 (63% vs 37%) and grade 2 (28% vs 72%), p=0.0007.
CONCLUSIONS: Tumour grade assessment is accurate in biopsies of liver metastases of pancreatic neuroendocrine tumours, while pancreatic fine-needle aspiration biopsies are less accurate.
Copyright © 2015 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ki67; Pancreatic neuroendocrine tumour; Preoperative biopsy accuracy

Mesh:

Substances:

Year:  2015        PMID: 26169284     DOI: 10.1016/j.dld.2015.06.005

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  15 in total

Review 1.  Early Gastroenteropancreatic Neuroendocrine Tumors: Endoscopic Therapy and Surveillance.

Authors:  Hans Scherübl; Guillaume Cadiot
Journal:  Visc Med       Date:  2017-10-10

2.  Reassessing the grade of gastroenteropancreatic neuroendocrine neoplasms.

Authors:  David S Klimstra
Journal:  Endocrine       Date:  2016-05-05       Impact factor: 3.633

3.  CT-derived radiomic features to discriminate histologic characteristics of pancreatic neuroendocrine tumors.

Authors:  Giulia Benedetti; Martina Mori; Marta Maria Panzeri; Maurizio Barbera; Diego Palumbo; Carla Sini; Francesca Muffatti; Valentina Andreasi; Stephanie Steidler; Claudio Doglioni; Stefano Partelli; Marco Manzoni; Massimo Falconi; Claudio Fiorino; Francesco De Cobelli
Journal:  Radiol Med       Date:  2021-02-01       Impact factor: 3.469

4.  Grading Pancreatic Neuroendocrine Tumors via Endoscopic Ultrasound-guided Fine Needle Aspiration: A Multi-Institutional Study.

Authors:  Ammar A Javed; Alessandra Pulvirenti; Samrah Razi; Jian Zheng; Theodoros Michelakos; Yurie Sekigami; Elizabeth Thompson; David S Klimstra; Vikram Deshpande; Aatur D Singhi; Matthew J Weiss; Christopher L Wolfgang; John L Cameron; Alice C Wei; Amer H Zureikat; Cristina R Ferrone; Jin He
Journal:  Ann Surg       Date:  2022-01-25       Impact factor: 13.787

5.  KI-67 heterogeneity in well differentiated gastro-entero-pancreatic neuroendocrine tumors: when is biopsy reliable for grade assessment?

Authors:  Federica Grillo; Luca Valle; Diego Ferone; Manuela Albertelli; Maria Pia Brisigotti; Giuseppe Cittadini; Alessandro Vanoli; Roberto Fiocca; Luca Mastracci
Journal:  Endocrine       Date:  2017-07-19       Impact factor: 3.633

6.  Interesting pancreatic tumour in the background of Tuberous Sclerosis.

Authors:  Jmv Amarjothi; Jeyasudhahar Jesudason; Villalan Ramasamy; Ol Naganath Babu
Journal:  BMJ Case Rep       Date:  2019-08-04

7.  Pancreatic neuroendocrine neoplasms: Magnetic resonance imaging features according to grade and stage.

Authors:  Riccardo De Robertis; Sara Cingarlini; Paolo Tinazzi Martini; Silvia Ortolani; Giovanni Butturini; Luca Landoni; Paolo Regi; Roberto Girelli; Paola Capelli; Stefano Gobbo; Giampaolo Tortora; Aldo Scarpa; Paolo Pederzoli; Mirko D'Onofrio
Journal:  World J Gastroenterol       Date:  2017-01-14       Impact factor: 5.742

8.  Fine-Needle Aspiration-Based Grading of Pancreatic Neuroendocrine Neoplasms Using Ki-67: Is Accurate WHO Grading Possible on Cytologic Material?

Authors:  Vivian L Weiss; Colleen Kiernan; Jesse Wright; Nipun B Merchant; Alice C Coogan; Chanjuan Shi
Journal:  J Am Soc Cytopathol       Date:  2018-02-13

9.  Quantitative Computed Tomography Image Analysis to Predict Pancreatic Neuroendocrine Tumor Grade.

Authors:  Alessandra Pulvirenti; Rikiya Yamashita; Jayasree Chakraborty; Natally Horvat; Kenneth Seier; Caitlin A McIntyre; Sharon A Lawrence; Abhishek Midya; Maura A Koszalka; Mithat Gonen; David S Klimstra; Diane L Reidy; Peter J Allen; Richard K G Do; Amber L Simpson
Journal:  JCO Clin Cancer Inform       Date:  2021-06

10.  Assessment of pancreatic neuroendocrine tumor cytologic genotype diversity to guide personalized medicine using a custom gastroenteropancreatic next-generation sequencing panel.

Authors:  Ferga C Gleeson; Jesse S Voss; Benjamin R Kipp; Sarah E Kerr; John S Van Arnam; John R Mills; Cherisse A Marcou; Amber R Schneider; Zheng Jin Tu; Michael R Henry; Michael J Levy
Journal:  Oncotarget       Date:  2017-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.